Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany—A retrospective analysis of real-world data
Crossref DOI link: https://doi.org/10.1007/s00198-017-4051-y
Published Online: 2017-04-29
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dombrowski, S.
Kostev, K.
Jacob, L.
License valid from 2017-04-29